Power and Sample Size Estimation for the Clustered Wilcoxon Test
Authors:
- 28 September 2010
- journal article
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 67 (2) , 646-653
Abstract
Summary The Wilcoxon rank sum test is widely used for two‐group comparisons of nonnormal data. An assumption of this test is independence of sampling units both within and between groups, which will be violated in the clustered data setting such as in ophthalmological clinical trials, where the unit of randomization is the subject, but the unit of analysis is the individual eye. For this purpose, we have proposed the clustered Wilcoxon test to account for clustering among multiple subunits within the same cluster ( Rosner, Glynn, and Lee, 2003 , Biometrics 59, 1089–1098; 2006, Biometrics 62, 1251–1259). However, power estimation is needed to plan studies that use this analytic approach. We have recently published methods for estimating power and sample size for the ordinary Wilcoxon rank sum test ( Rosner and Glynn, 2009 , Biometrics 65, 188–197). In this article we present extensions of this approach to estimate power for the clustered Wilcoxon test. Simulation studies show a good agreement between estimated and empirical power. These methods are illustrated with examples from randomized trials in ophthalmology. Enhanced power is achieved with use of the subunit as the unit of analysis instead of the cluster using the ordinary Wilcoxon rank sum test.Keywords
This publication has 11 references indexed in Scilit:
- Thet-TestpValue and Its Relationship to the Effect Size andP(X>Y)The American Statistician, 2010
- Power and Sample Size Estimation for the Wilcoxon Rank Sum Test with Application to Comparisons of C Statistics from Alternative Prediction ModelsBiometrics, 2009
- Extension of the Rank Sum Test for Clustered Data: Two‐Group Comparisons with Group Membership Defined at the Subunit LevelBiometrics, 2006
- Rank-Sum Tests for Clustered DataJournal of the American Statistical Association, 2005
- The Wilcoxon Signed-Rank Test for Cluster Correlated Data2005
- Further Evaluation of Docosahexaenoic Acid in Patients With RetinitisPigmentosa Receiving Vitamin A TreatmentArchives of Ophthalmology (1950), 2004
- Clinical Trial of Docosahexaenoic Acid in Patients With Retinitis PigmentosaReceiving Vitamin A TreatmentArchives of Ophthalmology (1950), 2004
- Incorporation of Clustering Effects for the Wilcoxon Rank Sum Test: A Large‐Sample ApproachBiometrics, 2003
- A Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis PigmentosaArchives of Ophthalmology (1950), 1993
- A Randomized Trial of Sorbinil, an Aldose Reductase Inhibitor, in Diabetic RetinopathyArchives of Ophthalmology (1950), 1990